0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Testing for Infectious Diseases Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-6W16894
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global In Vitro Testing for Infectious Diseases Market Research Report 2024
BUY CHAPTERS

Global In Vitro Testing for Infectious Diseases Market Research Report 2025

Code: QYRE-Auto-6W16894
Report
September 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vitro Testing for Infectious Diseases Market Size

The global market for In Vitro Testing for Infectious Diseases was valued at US$ 31330 million in the year 2024 and is projected to reach a revised size of US$ 51310 million by 2031, growing at a CAGR of 7.4% during the forecast period.

In Vitro Testing for Infectious Diseases Market

In Vitro Testing for Infectious Diseases Market

In vitro diagnostic (IVD) testing for infectious diseases involves laboratory-based analysis of biological samples, such as blood, urine, or swabs, to detect the presence of infectious agents or markers associated with infections. These tests play a crucial role in the diagnosis, monitoring, and management of infectious diseases.
The In Vitro Testing for Infectious Diseases market is driven by the global demand for rapid and accurate diagnostic solutions, particularly in the context of infectious diseases. In vitro diagnostic devices, encompassing molecular assays, immunoassays, and nucleic acid-based tests, play a pivotal role in the early detection and management of infectious pathogens. The ongoing threat of pandemics, such as the COVID-19 pandemic, has accelerated the need for advanced testing technologies. Additionally, the increasing prevalence of infectious diseases worldwide, coupled with initiatives to control their spread, fuels the market"s growth. Technological innovations, including point-of-care testing, contribute to the market"s dynamism, addressing the urgent need for timely and reliable infectious disease diagnostics.
This report aims to provide a comprehensive presentation of the global market for In Vitro Testing for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Testing for Infectious Diseases.
The In Vitro Testing for Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Testing for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Testing for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vitro Testing for Infectious Diseases Market Report

Report Metric Details
Report Name In Vitro Testing for Infectious Diseases Market
Accounted market size in year US$ 31330 million
Forecasted market size in 2031 US$ 51310 million
CAGR 7.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Consumables
  • Equipment
Segment by Application
  • Hepatitis
  • Pneumonia
  • Sexually Transmitted Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, Leadman, Zhongsheng, Bsbe, Maccura, Hitachi, Canon, Sysmex, Auto Bio, Mindray, Bgi, Wondfo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In Vitro Testing for Infectious Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is In Vitro Testing for Infectious Diseases Market growing?

Ans: The In Vitro Testing for Infectious Diseases Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the In Vitro Testing for Infectious Diseases Market size in 2031?

Ans: The In Vitro Testing for Infectious Diseases Market size in 2031 will be US$ 51310 million.

Who are the main players in the In Vitro Testing for Infectious Diseases Market report?

Ans: The main players in the In Vitro Testing for Infectious Diseases Market are Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, Leadman, Zhongsheng, Bsbe, Maccura, Hitachi, Canon, Sysmex, Auto Bio, Mindray, Bgi, Wondfo

What are the Application segmentation covered in the In Vitro Testing for Infectious Diseases Market report?

Ans: The Applications covered in the In Vitro Testing for Infectious Diseases Market report are Hepatitis, Pneumonia, Sexually Transmitted Diseases, Other

What are the Type segmentation covered in the In Vitro Testing for Infectious Diseases Market report?

Ans: The Types covered in the In Vitro Testing for Infectious Diseases Market report are Consumables, Equipment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Consumables
1.2.3 Equipment
1.3 Market by Application
1.3.1 Global In Vitro Testing for Infectious Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hepatitis
1.3.3 Pneumonia
1.3.4 Sexually Transmitted Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Testing for Infectious Diseases Market Perspective (2020-2031)
2.2 Global In Vitro Testing for Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Testing for Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Testing for Infectious Diseases Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Testing for Infectious Diseases Market Dynamics
2.3.1 In Vitro Testing for Infectious Diseases Industry Trends
2.3.2 In Vitro Testing for Infectious Diseases Market Drivers
2.3.3 In Vitro Testing for Infectious Diseases Market Challenges
2.3.4 In Vitro Testing for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Testing for Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Testing for Infectious Diseases Players by Revenue (2020-2025)
3.1.2 Global In Vitro Testing for Infectious Diseases Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Testing for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Testing for Infectious Diseases Revenue
3.4 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Testing for Infectious Diseases Revenue in 2024
3.5 Global Key Players of In Vitro Testing for Infectious Diseases Head office and Area Served
3.6 Global Key Players of In Vitro Testing for Infectious Diseases, Product and Application
3.7 Global Key Players of In Vitro Testing for Infectious Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Testing for Infectious Diseases Breakdown Data by Type
4.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2026-2031)
5 In Vitro Testing for Infectious Diseases Breakdown Data by Application
5.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Testing for Infectious Diseases Market Size (2020-2031)
6.2 North America In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025)
6.4 North America In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Testing for Infectious Diseases Market Size (2020-2031)
7.2 Europe In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025)
7.4 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Testing for Infectious Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Testing for Infectious Diseases Market Size (2020-2031)
9.2 Latin America In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025)
9.4 Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche In Vitro Testing for Infectious Diseases Introduction
11.1.4 Roche Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens In Vitro Testing for Infectious Diseases Introduction
11.2.4 Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Testing for Infectious Diseases Introduction
11.3.4 Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher In Vitro Testing for Infectious Diseases Introduction
11.4.4 Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Details
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher In Vitro Testing for Infectious Diseases Introduction
11.5.4 Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.5.5 Thermo Fisher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux In Vitro Testing for Infectious Diseases Introduction
11.6.4 BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.6.5 BioMerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad In Vitro Testing for Infectious Diseases Introduction
11.7.4 Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.7.5 Bio-Rad Recent Development
11.8 BD
11.8.1 BD Company Details
11.8.2 BD Business Overview
11.8.3 BD In Vitro Testing for Infectious Diseases Introduction
11.8.4 BD Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.8.5 BD Recent Development
11.9 KHB
11.9.1 KHB Company Details
11.9.2 KHB Business Overview
11.9.3 KHB In Vitro Testing for Infectious Diseases Introduction
11.9.4 KHB Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.9.5 KHB Recent Development
11.10 Daan Gene
11.10.1 Daan Gene Company Details
11.10.2 Daan Gene Business Overview
11.10.3 Daan Gene In Vitro Testing for Infectious Diseases Introduction
11.10.4 Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.10.5 Daan Gene Recent Development
11.11 Leadman
11.11.1 Leadman Company Details
11.11.2 Leadman Business Overview
11.11.3 Leadman In Vitro Testing for Infectious Diseases Introduction
11.11.4 Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.11.5 Leadman Recent Development
11.12 Zhongsheng
11.12.1 Zhongsheng Company Details
11.12.2 Zhongsheng Business Overview
11.12.3 Zhongsheng In Vitro Testing for Infectious Diseases Introduction
11.12.4 Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.12.5 Zhongsheng Recent Development
11.13 Bsbe
11.13.1 Bsbe Company Details
11.13.2 Bsbe Business Overview
11.13.3 Bsbe In Vitro Testing for Infectious Diseases Introduction
11.13.4 Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.13.5 Bsbe Recent Development
11.14 Maccura
11.14.1 Maccura Company Details
11.14.2 Maccura Business Overview
11.14.3 Maccura In Vitro Testing for Infectious Diseases Introduction
11.14.4 Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.14.5 Maccura Recent Development
11.15 Hitachi
11.15.1 Hitachi Company Details
11.15.2 Hitachi Business Overview
11.15.3 Hitachi In Vitro Testing for Infectious Diseases Introduction
11.15.4 Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.15.5 Hitachi Recent Development
11.16 Canon
11.16.1 Canon Company Details
11.16.2 Canon Business Overview
11.16.3 Canon In Vitro Testing for Infectious Diseases Introduction
11.16.4 Canon Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.16.5 Canon Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Details
11.17.2 Sysmex Business Overview
11.17.3 Sysmex In Vitro Testing for Infectious Diseases Introduction
11.17.4 Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.17.5 Sysmex Recent Development
11.18 Auto Bio
11.18.1 Auto Bio Company Details
11.18.2 Auto Bio Business Overview
11.18.3 Auto Bio In Vitro Testing for Infectious Diseases Introduction
11.18.4 Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.18.5 Auto Bio Recent Development
11.19 Mindray
11.19.1 Mindray Company Details
11.19.2 Mindray Business Overview
11.19.3 Mindray In Vitro Testing for Infectious Diseases Introduction
11.19.4 Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.19.5 Mindray Recent Development
11.20 Bgi
11.20.1 Bgi Company Details
11.20.2 Bgi Business Overview
11.20.3 Bgi In Vitro Testing for Infectious Diseases Introduction
11.20.4 Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.20.5 Bgi Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Details
11.21.2 Wondfo Business Overview
11.21.3 Wondfo In Vitro Testing for Infectious Diseases Introduction
11.21.4 Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025)
11.21.5 Wondfo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Consumables
 Table 3. Key Players of Equipment
 Table 4. Global In Vitro Testing for Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global In Vitro Testing for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global In Vitro Testing for Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global In Vitro Testing for Infectious Diseases Market Share by Region (2020-2025)
 Table 8. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global In Vitro Testing for Infectious Diseases Market Share by Region (2026-2031)
 Table 10. In Vitro Testing for Infectious Diseases Market Trends
 Table 11. In Vitro Testing for Infectious Diseases Market Drivers
 Table 12. In Vitro Testing for Infectious Diseases Market Challenges
 Table 13. In Vitro Testing for Infectious Diseases Market Restraints
 Table 14. Global In Vitro Testing for Infectious Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global In Vitro Testing for Infectious Diseases Market Share by Players (2020-2025)
 Table 16. Global Top In Vitro Testing for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2024)
 Table 17. Ranking of Global Top In Vitro Testing for Infectious Diseases Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by In Vitro Testing for Infectious Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of In Vitro Testing for Infectious Diseases, Headquarters and Area Served
 Table 20. Global Key Players of In Vitro Testing for Infectious Diseases, Product and Application
 Table 21. Global Key Players of In Vitro Testing for Infectious Diseases, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global In Vitro Testing for Infectious Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2020-2025)
 Table 25. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2026-2031)
 Table 27. Global In Vitro Testing for Infectious Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Application (2020-2025)
 Table 29. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Application (2026-2031)
 Table 31. North America In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Roche Company Details
 Table 47. Roche Business Overview
 Table 48. Roche In Vitro Testing for Infectious Diseases Product
 Table 49. Roche Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 50. Roche Recent Development
 Table 51. Siemens Company Details
 Table 52. Siemens Business Overview
 Table 53. Siemens In Vitro Testing for Infectious Diseases Product
 Table 54. Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 55. Siemens Recent Development
 Table 56. Abbott Company Details
 Table 57. Abbott Business Overview
 Table 58. Abbott In Vitro Testing for Infectious Diseases Product
 Table 59. Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 60. Abbott Recent Development
 Table 61. Danaher Company Details
 Table 62. Danaher Business Overview
 Table 63. Danaher In Vitro Testing for Infectious Diseases Product
 Table 64. Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 65. Danaher Recent Development
 Table 66. Thermo Fisher Company Details
 Table 67. Thermo Fisher Business Overview
 Table 68. Thermo Fisher In Vitro Testing for Infectious Diseases Product
 Table 69. Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 70. Thermo Fisher Recent Development
 Table 71. BioMerieux Company Details
 Table 72. BioMerieux Business Overview
 Table 73. BioMerieux In Vitro Testing for Infectious Diseases Product
 Table 74. BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 75. BioMerieux Recent Development
 Table 76. Bio-Rad Company Details
 Table 77. Bio-Rad Business Overview
 Table 78. Bio-Rad In Vitro Testing for Infectious Diseases Product
 Table 79. Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 80. Bio-Rad Recent Development
 Table 81. BD Company Details
 Table 82. BD Business Overview
 Table 83. BD In Vitro Testing for Infectious Diseases Product
 Table 84. BD Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 85. BD Recent Development
 Table 86. KHB Company Details
 Table 87. KHB Business Overview
 Table 88. KHB In Vitro Testing for Infectious Diseases Product
 Table 89. KHB Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 90. KHB Recent Development
 Table 91. Daan Gene Company Details
 Table 92. Daan Gene Business Overview
 Table 93. Daan Gene In Vitro Testing for Infectious Diseases Product
 Table 94. Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 95. Daan Gene Recent Development
 Table 96. Leadman Company Details
 Table 97. Leadman Business Overview
 Table 98. Leadman In Vitro Testing for Infectious Diseases Product
 Table 99. Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 100. Leadman Recent Development
 Table 101. Zhongsheng Company Details
 Table 102. Zhongsheng Business Overview
 Table 103. Zhongsheng In Vitro Testing for Infectious Diseases Product
 Table 104. Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 105. Zhongsheng Recent Development
 Table 106. Bsbe Company Details
 Table 107. Bsbe Business Overview
 Table 108. Bsbe In Vitro Testing for Infectious Diseases Product
 Table 109. Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 110. Bsbe Recent Development
 Table 111. Maccura Company Details
 Table 112. Maccura Business Overview
 Table 113. Maccura In Vitro Testing for Infectious Diseases Product
 Table 114. Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 115. Maccura Recent Development
 Table 116. Hitachi Company Details
 Table 117. Hitachi Business Overview
 Table 118. Hitachi In Vitro Testing for Infectious Diseases Product
 Table 119. Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 120. Hitachi Recent Development
 Table 121. Canon Company Details
 Table 122. Canon Business Overview
 Table 123. Canon In Vitro Testing for Infectious Diseases Product
 Table 124. Canon Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 125. Canon Recent Development
 Table 126. Sysmex Company Details
 Table 127. Sysmex Business Overview
 Table 128. Sysmex In Vitro Testing for Infectious Diseases Product
 Table 129. Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 130. Sysmex Recent Development
 Table 131. Auto Bio Company Details
 Table 132. Auto Bio Business Overview
 Table 133. Auto Bio In Vitro Testing for Infectious Diseases Product
 Table 134. Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 135. Auto Bio Recent Development
 Table 136. Mindray Company Details
 Table 137. Mindray Business Overview
 Table 138. Mindray In Vitro Testing for Infectious Diseases Product
 Table 139. Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 140. Mindray Recent Development
 Table 141. Bgi Company Details
 Table 142. Bgi Business Overview
 Table 143. Bgi In Vitro Testing for Infectious Diseases Product
 Table 144. Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 145. Bgi Recent Development
 Table 146. Wondfo Company Details
 Table 147. Wondfo Business Overview
 Table 148. Wondfo In Vitro Testing for Infectious Diseases Product
 Table 149. Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 150. Wondfo Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. In Vitro Testing for Infectious Diseases Picture
 Figure 2. Global In Vitro Testing for Infectious Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vitro Testing for Infectious Diseases Market Share by Type: 2024 VS 2031
 Figure 4. Consumables Features
 Figure 5. Equipment Features
 Figure 6. Global In Vitro Testing for Infectious Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global In Vitro Testing for Infectious Diseases Market Share by Application: 2024 VS 2031
 Figure 8. Hepatitis Case Studies
 Figure 9. Pneumonia Case Studies
 Figure 10. Sexually Transmitted Diseases Case Studies
 Figure 11. Other Case Studies
 Figure 12. In Vitro Testing for Infectious Diseases Report Years Considered
 Figure 13. Global In Vitro Testing for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global In Vitro Testing for Infectious Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global In Vitro Testing for Infectious Diseases Market Share by Region: 2024 VS 2031
 Figure 16. Global In Vitro Testing for Infectious Diseases Market Share by Players in 2024
 Figure 17. Global Top In Vitro Testing for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by In Vitro Testing for Infectious Diseases Revenue in 2024
 Figure 19. North America In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America In Vitro Testing for Infectious Diseases Market Share by Country (2020-2031)
 Figure 21. United States In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe In Vitro Testing for Infectious Diseases Market Share by Country (2020-2031)
 Figure 25. Germany In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific In Vitro Testing for Infectious Diseases Market Share by Region (2020-2031)
 Figure 33. China In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America In Vitro Testing for Infectious Diseases Market Share by Country (2020-2031)
 Figure 41. Mexico In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa In Vitro Testing for Infectious Diseases Market Share by Country (2020-2031)
 Figure 45. Turkey In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE In Vitro Testing for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Roche Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 49. Siemens Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 50. Abbott Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 51. Danaher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 52. Thermo Fisher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 53. BioMerieux Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 54. Bio-Rad Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 55. BD Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 56. KHB Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 57. Daan Gene Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 58. Leadman Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 59. Zhongsheng Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 60. Bsbe Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 61. Maccura Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 62. Hitachi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 63. Canon Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 64. Sysmex Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 65. Auto Bio Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 66. Mindray Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 67. Bgi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 68. Wondfo Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS